Vuzix Earnings Calls
| Release date | May 14, 2026 |
| EPS estimate | -$0.100 |
| EPS actual | -$0.0900 |
| EPS Surprise | 10.00% |
| Revenue estimate | 1.346M |
| Revenue actual | 1.391M |
| Revenue Surprise | 3.34% |
| Release date | Mar 12, 2026 |
| EPS estimate | -$0.0900 |
| EPS actual | -$0.120 |
| EPS Surprise | -33.33% |
| Revenue estimate | 1.916M |
| Revenue actual | 2.243M |
| Revenue Surprise | 17.07% |
| Release date | Nov 13, 2025 |
| EPS estimate | -$0.100 |
| EPS actual | -$0.0900 |
| EPS Surprise | 10.00% |
| Revenue estimate | 1.916M |
| Revenue actual | 1.161M |
| Revenue Surprise | -39.41% |
| Release date | Aug 14, 2025 |
| EPS estimate | -$0.120 |
| EPS actual | -$0.100 |
| EPS Surprise | 16.67% |
| Revenue estimate | 2.198M |
| Revenue actual | 1.296M |
| Revenue Surprise | -41.05% |
Last 4 Quarters for Vuzix
Below you can see how VUZI performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Aug 14, 2025 |
| Price on release | $2.20 |
| EPS estimate | -$0.120 |
| EPS actual | -$0.100 |
| EPS surprise | 16.67% |
| Date | Price |
|---|---|
| Aug 08, 2025 | $2.07 |
| Aug 11, 2025 | $2.00 |
| Aug 12, 2025 | $2.20 |
| Aug 13, 2025 | $2.32 |
| Aug 14, 2025 | $2.20 |
| Aug 15, 2025 | $2.02 |
| Aug 18, 2025 | $1.99 |
| Aug 19, 2025 | $1.90 |
| Aug 20, 2025 | $1.93 |
| 4 days before | 6.54% |
| 4 days after | -12.27% |
| On release day | -8.18% |
| Change in period | -6.54% |
| Release date | Nov 13, 2025 |
| Price on release | $2.45 |
| EPS estimate | -$0.100 |
| EPS actual | -$0.0900 |
| EPS surprise | 10.00% |
| Date | Price |
|---|---|
| Nov 07, 2025 | $2.85 |
| Nov 10, 2025 | $2.75 |
| Nov 11, 2025 | $2.62 |
| Nov 12, 2025 | $2.70 |
| Nov 13, 2025 | $2.45 |
| Nov 14, 2025 | $2.26 |
| Nov 17, 2025 | $2.13 |
| Nov 18, 2025 | $2.18 |
| Nov 19, 2025 | $2.18 |
| 4 days before | -14.04% |
| 4 days after | -11.02% |
| On release day | -7.76% |
| Change in period | -23.51% |
| Release date | Mar 12, 2026 |
| Price on release | $2.55 |
| EPS estimate | -$0.0900 |
| EPS actual | -$0.120 |
| EPS surprise | -33.33% |
| Date | Price |
|---|---|
| Mar 06, 2026 | $2.55 |
| Mar 09, 2026 | $2.59 |
| Mar 10, 2026 | $2.55 |
| Mar 11, 2026 | $2.59 |
| Mar 12, 2026 | $2.55 |
| Mar 13, 2026 | $2.19 |
| Mar 16, 2026 | $2.11 |
| Mar 17, 2026 | $2.13 |
| Mar 18, 2026 | $2.03 |
| 4 days before | 0% |
| 4 days after | -20.39% |
| On release day | -14.12% |
| Change in period | -20.39% |
| Release date | May 14, 2026 |
| Price on release | $3.08 |
| EPS estimate | -$0.100 |
| EPS actual | -$0.0900 |
| EPS surprise | 10.00% |
| Date | Price |
|---|---|
| May 08, 2026 | $3.11 |
| May 11, 2026 | $3.05 |
| May 12, 2026 | $2.90 |
| May 13, 2026 | $3.02 |
| May 14, 2026 | $3.08 |
| May 15, 2026 | $3.00 |
| May 18, 2026 | $3.65 |
| May 19, 2026 | $4.11 |
| May 20, 2026 | $4.52 |
| 4 days before | -0.96% |
| 4 days after | 46.75% |
| On release day | -2.60% |
| Change in period | 45.34% |
Vuzix Earnings Call Transcript Summary of Q1 2026
Vuzix reported Q1 2026 revenue of $1.4M (down 12% YoY) with product sales weakness (M400) offset partially by a 36% increase in engineering services. Gross loss widened slightly due to lower sales and fixed cost absorption. Operating expenses declined 20% YoY to $6.8M driven largely by a $1.7M reduction in noncash stock-based compensation; R&D increased ~16% as the company invested in personnel and new waveguide equipment. Cash and equivalents were $20.2M at quarter-end, with operating cash use of $5.6M; financing proceeds from the ATM provided $5.8M. Management reiterates a two-pronged growth strategy focused on OEM/ODM smart glasses programs and scaling U.S.-based waveguide design/manufacturing, citing expanding customer programs (Amazon, an auto manufacturer, Collins Aerospace, Tier 1 defense supplier) including Q2 EVT-based OEM shipments to Amazon and multiple defense-related engagements (including a forthcoming 7-figure DoD-funded waveguide program). The company is expanding Rochester manufacturing and chemistry lab capabilities to support scale, and believes its cash position and disciplined cost structure provide runway into 2027. Key near-term investor considerations: modest current revenue with continuing R&D and capex investment, improving OEM/defense traction and customer-funded development programs that could convert to larger production orders, and a stated plan to scale waveguide manufacturing as the strategic long-term revenue driver.
Sign In
Buy VUZI